risperidon "medochemie" 8 mg filmovertrukne tabletter
medochemie ltd - risperidon - filmovertrukne tabletter - 8 mg
temozolomid "stada" 100 mg kapsler, hårde
stada arzneimittel ag - temozolomid - kapsler, hårde - 100 mg
temozolomid "stada" 140 mg kapsler, hårde
stada arzneimittel ag - temozolomid - kapsler, hårde - 140 mg
temozolomid "stada" 180 mg kapsler, hårde
stada arzneimittel ag - temozolomid - kapsler, hårde - 180 mg
temozolomid "stada" 20 mg kapsler, hårde
stada arzneimittel ag - temozolomid - kapsler, hårde - 20 mg
temozolomid "stada" 250 mg kapsler, hårde
stada arzneimittel ag - temozolomid - kapsler, hårde - 250 mg
oroganic flydende middel
borregaard bioplant - penetreringsolie - flydende middel - 1000 g/l penetreringsolie
takla flydende middel
pro farm oü - kobber - flydende middel - 5,4 g/l kobber
bettamousse 1 mg/g kutanskum
orifarm a/s - betamethasonvalerat - kutanskum - 1 mg/g
orserdu
stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.